News

Published on 4 May 2024 on Simply Wall St. via Yahoo Finance

Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next


Article preview image

Bio-Techne Corporation (NASDAQ:TECH) defied analyst predictions to release its quarterly results, which were ahead of market expectations. The company beat expectations with revenues of US$303m arriving 3.6% ahead of forecasts. Statutory earnings per share (EPS) were US$0.31, 7.6% ahead of estimates. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

View our latest analysis for Bio-Techne

earnings-and-revenue-growthearnings-and-revenue-growth

NASDAQ.TECH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here’s What Dragged Bio-Techne Corporation (TECH)?

Brown Capital Management, an investment management company, released its “The Brown Capital Manag...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Bio-Techne Corporation (TECH) Declined on Weak Q4 Results

Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024...

Insider Monkey via Yahoo Finance 15 May 2024

Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next

Bio-Techne Corporation (NASDAQ:TECH) defied analyst predictions to release its quarterly results,...

Simply Wall St. via Yahoo Finance 4 May 2024

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corp...

Insider Monkey via Yahoo Finance 3 May 2024

Earnings call: Bio-Techne sees growth in Q3 with strong market positioning

Bio-Techne (NASDAQ: TECH ) Corporation ( NASDAQ : TECH) reported a 2% year-over-year organic reve...

Investing.com 2 May 2024

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corp...

Insider Monkey via Yahoo Finance 2 May 2024

Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50....

Simply Wall St. via Yahoo Finance 1 May 2024

Bio-Techne (NASDAQ:TECH) shareholders have earned a 7.4% CAGR over the last five years

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd l...

Simply Wall St. via Yahoo Finance 1 Apr 2024

What Does Bio-Techne Corporation's (NASDAQ:TECH) Share Price Indicate?

Today we're going to take a look at the well-established Bio-Techne Corporation (NASDAQ:TECH). Th...

Simply Wall St. via Yahoo Finance 2 Mar 2024

What Makes Bio-Techne Corporation (TECH) an Investment Bet?

Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Str...

Insider Monkey via Yahoo Finance 23 Feb 2024